HLA-characterized human primary cells are isolated from ethically obtained human tissues and maintained at early passage numbers. The available cell populations include endothelial cells, epithelial cells, fibroblasts, and smooth muscle cells. Each cell product is characterized by high-resolution Human Leukocyte Antigen (HLA) typing, covering both Class I and Class II loci through next-generation sequencing (NGS) and/or PCR-based sequence-based typing (PCR-SBT). These cells serve as immunogenetically defined biological models for allogeneic tissue engineering, organ-on-a-chip platforms, transplantation research, cell-matrix interaction studies, and targeted toxicity screening.
Creative Biolabs offers a comprehensive catalog of characterized tissue-derived HLA-typed primary cells featuring:
To guarantee optimal post-thaw performance and lot-to-lot reproducibility, all cryopreserved tissue-derived primary cells are processed through our standardized quality control pipeline:
Ethical Donor Tissue Procurement → Primary Cell Isolation and Early-Passage Expansion (P1–P2) → High-Resolution HLA Allele Characterization → Cell Identity Verification and Post-Thaw Viability Assessment → Cryogenic Storage in the Vapor Phase
| Key Advantage | Technical Feature | Research Value |
| Diverse Tissue Subtypes | Endothelial, epithelial, fibroblast, and smooth muscle cells | Enables organ-specific and multi-cellular human disease modeling |
| Defined Immunogenetics | 4-Digit / 6-Digit NGS HLA Genotyping | Enables controlled studies of HLA-associated cellular interactions and donor-specific responses |
| Low Passage & High Viability | P1-P3 Cryopreserved Vials with 80% Post-Thaw Viability | Preserves primary physiological traits and supports extended in vitro experimental use |
| Matched Donor Panels | Some cell types derived from the same donor tissue, where available | Supports donor-matched cellular models and multicellular co-culture studies |
a) Engineered Human Tissues and Organ-on-a-Chip Platforms: Developing vascularized tissue models and three-dimensional microphysiological systems using primary cells with documented HLA profiles.
b) Transplant Compatibility and Immune Reactivity Studies: Examining HLA-associated immune responses, including endothelial and epithelial cell interactions with donor-specific antibodies and T-cell-driven cytotoxic effects.
c) Immune–Stromal Interaction Models: Studying communication between immune and stromal cell populations, including immune cell migration across tissue barriers, tissue infiltration, and cellular interactions in HLA-compatible or HLA-disparate co-culture systems.
d) Tissue-Specific Drug Safety Assessment: Investigating compound-induced cellular injury and cytotoxicity in primary cell models representing different organs and defined donor HLA profiles.
Q1: Which tissue cell types are available with HLA typing data?
A1: We provide HLA-typed human primary endothelial cells, epithelial cells, fibroblasts, and smooth muscle cells isolated from various human organs (skin, lung, blood vessels, kidney, etc.).
Q2: Can I obtain multiple tissue cell types derived from the same HLA-typed donor?
A2: Yes. We offer matched donor cell sets (e.g., HLA-typed endothelial cells and smooth muscle cells from the same vascular donor tissue) to support complex autologous co-culture experiments.
Q3: What passage number are these cryopreserved HLA-typed cells?
A3: Most of our tissue-derived primary cells are cryopreserved at early passages to ensure maximum proliferative potential and physiological relevance.